Turning Point Therapeutics, Inc. (TPTX) Earning

NASDAQ Currency in USD Disclaimer

$75.49

north_east NA Past Year
Day's range
$75.3
Day's range
$75.77

Turning Point Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/08/2022 Q2 2022 -$1.70 -$2.48 -0.78 $119,000
05/10/2022 Q1 2022 -$1.51 -$1.50 0.01 $429,000
02/28/2022 Q4 2021 -$1.39 -$1.58 -0.19 $25,205
11/09/2021 Q3 2021 -$1.27 -$1.34 -0.07 $460,000
08/09/2021 Q2 2021 -$1.21 -$1.14 0.07 $5.16 M
05/05/2021 Q1 2021 -$0.61 -$0.73 -0.12 $25.21 M
03/01/2021 Q4 2020 -$0.92 -$1.02 -0.1 $0
11/12/2020 Q3 2020 -$0.54 -$0.42 0.12 $25.00 M
08/10/2020 Q2 2020 -$0.89 -$0.82 0.07 $0
05/12/2020 Q1 2020 -$0.66 -$1.69 -1.03 $0
03/17/2020 Q4 2019 -$0.58 $0
11/04/2019 Q3 2019 -$0.55 -$0.63 -0.08 $0
08/06/2019 Q2 2019 -$0.65 -$0.70 -0.05 $0
05/31/2019 Q1 2019 -$0.69 -$0.49 0.2 $0
12/30/2018 Q4 2018 -$0.32 $0
09/29/2018 Q3 2018 -$0.40 $0
06/29/2018 Q2 2018 -$0.34 $0
03/30/2018 Q1 2018 -$0.32 $0
 

Turning Point Therapeutics, Inc. Earnings: FAQ's

When is Turning Point Therapeutics, Inc.'s earnings date?

Turning Point Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 8th, 2022 based off last year's report dates.

How can I listen to Turning Point Therapeutics, Inc.'s earnings conference call?

The conference call for Turning Point Therapeutics, Inc.'s latest earnings report can be listened to online.

How can I read Turning Point Therapeutics, Inc.'s conference call transcript?

The conference call transcript for Turning Point Therapeutics, Inc.'s latest earnings report can be read online.

How much revenue does Turning Point Therapeutics, Inc. generate each year?

Turning Point Therapeutics, Inc. (:TPTX) has a recorded annual revenue of $30.83 M.

How much profit does Turning Point Therapeutics, Inc. generate each year?

Turning Point Therapeutics, Inc. (:TPTX) has a recorded net income of $30.83 M. Turning Point Therapeutics, Inc. has generated $-5.79 earnings per share over the last four quarters.

What is Turning Point Therapeutics, Inc.'s price-to-earnings ratio?

Turning Point Therapeutics, Inc. (:TPTX) has a price-to-earnings ratio of -13.03 and price/earnings-to-growth ratio is -0.13.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED